Cargando…

Effects of cinacalcet treatment on QT interval in hemodialysis patients

OBJECTIVE: Cinacalcet is a calcimimetic drug that acts via calcium-sensing receptors (CaSRs) and increases the sensitivity of CaSRs on the parathyroid gland; thus, it lowers calcium and phosphorus levels as well as parathormone levels. Prolongation of the QT interval is recognized as a risk factor f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Temiz, Gökhan, Yalçın, Ahmet Uğur, Mutluay, Rüya, Bozacı, İlter, Bal, Cengiz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2016
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331400/ https://www.ncbi.nlm.nih.gov/pubmed/27004702 http://dx.doi.org/10.5152/AnatolJCardiol.2015.6284

Ejemplares similares

A Study of QT Interval and QT Dispersion During Laparoscopic Cholecystectomy
por: Parikh, Heena, et al.
Publicado: (2009)

Effect of Hemodialysis on Corrected QT Interval and QTc Dispersion
por: Sohal, P. M., et al.
Publicado: (2018)

QT Interval and QT Dispersion in Patients Undergoing Hemodialysis: Revisiting the Old Theory
por: Alabd, Mohamed A., et al.
Publicado: (2011)

Evaluation of the Tp-Te interval, Tp-Te/QTc ratio, and QT dispersion in patients with Turner syndrome
por: Atıcı, Adem, et al.
Publicado: (2018)

Parathyroidectomy Versus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
por: Alvarado, Luis, et al.
Publicado: (2022)

Influence of the left ventricular types on QT intervals in hypertensive patients
por: Kunisek, Juraj, et al.
Publicado: (2015)

Electrocardiographic Abnormalities and QT(c) Interval in Patients Undergoing Hemodialysis
por: Nie, Yuxin, et al.
Publicado: (2016)

Lanthanum carbonate is not associated with QT interval modification in hemodialysis patients
por: Di Iorio, Biagio, et al.
Publicado: (2010)

The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study
por: Ring, Arne, et al.
Publicado: (2013)

PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism
por: Akizawa, Tadao, et al.
Publicado: (2016)

Effects of hydroxychloroquine treatment on QT interval
por: Hooks, Matthew, et al.
Publicado: (2020)

Evaluation of Tpe interval and Tpe/QT ratio in patients with slow coronary flow
por: Zehir, Regayip, et al.
Publicado: (2015)

Evaluation of Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio in patients with mitral valve stenosis before and after balloon valvuloplasty
por: Dural, Muhammet, et al.
Publicado: (2017)

Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval
por: Michel, Holger, et al.
Publicado: (2023)

Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism
por: Kuczera, Piotr, et al.
Publicado: (2016)

Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events Trial
Publicado: (2015)

The Measurement of the QT Interval
por: Postema, Pieter G, et al.
Publicado: (2014)

The QT Interval in Research
por: Somberg, John
Publicado: (2021)

Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial
por: Wheeler, David C., et al.
Publicado: (2014)

Prolongation of QT interval due to hydroxychloroquine overdose used in COVID-19 treatment
por: Aksel, Gökhan, et al.
Publicado: (2020)

Association between the corrected QT interval, carotid artery intima-media thickness, and hepatic steatosis in obese children
por: Daar, Ghaniya, et al.
Publicado: (2016)

Cinacalcet Treatment of Primary Hyperparathyroidism
por: Rothe, H. M., et al.
Publicado: (2011)

Evaluation of Tp–e interval, Tp–e/QT ratio, and Tp–e/QTc ratio in patients with Behçet’s disease
por: Hidayet, Şıho, et al.
Publicado: (2019)

Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic
por: Rubin, Geoffrey A., et al.
Publicado: (2021)

Issues in QT interval measurement
por: Lanjewar, Pallavi, et al.
Publicado: (2004)

Measuring the QT interval on the go
por: McIntyre, William F., et al.
Publicado: (2021)

Long-term effect of cinacalcet hydrochloride on abdominal aortic calcification in patients on hemodialysis with secondary hyperparathyroidism
por: Nakayama, Kazunori, et al.
Publicado: (2013)

Effects of balanced propofol sedation on QT, corrected QT, and P-wave dispersion on upper endoscopy
por: Bolat, Esef, et al.
Publicado: (2016)

The association between QT interval changes and the treatment protocols of COVID-19 patients
por: Sertbas, Yasar, et al.
Publicado: (2022)

Manual vs. automatic assessment of the QT-interval and corrected QT
por: Neumann, Benjamin, et al.
Publicado: (2023)

Partial response to cinacalcet treatment in a patient with secondary hyperparathyroidism undergoing hemodialysis: a case report
por: Conzo, Giovanni, et al.
Publicado: (2012)

The impact of CASR A990G polymorphism in response to cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism
por: Ngamkam, Jaruwan, et al.
Publicado: (2021)

A case of a hemodialysis patient with secondary hyperparathyroidism who was resistant to etelcalcetide treatment but not to cinacalcet hydrochloride
por: Nakamura, Hironori, et al.
Publicado: (2021)

Pain Assessment in Hemodialysis Patients
por: Sadigova, Esmira, et al.
Publicado: (2020)

Investigation of the Proarrhythmic Effects of Antidepressants according to QT Interval, QT Dispersion and T Wave Peak-to-End Interval in the Clinical Setting
por: Okayasu, Hiroaki, et al.
Publicado: (2019)

Assessment of Tp-Te Interval and Tp-Te/Qt Ratio in Patients with Aortic Aneurysm
por: Boduroglu, Yalcin, et al.
Publicado: (2019)

Gallstones were associated with the gastrointestinal adverse events of cinacalcet in hemodialysis patients with secondary hyperparathyroidism
por: Otsuka, Keiichi, et al.
Publicado: (2018)

Predictors of cinacalcet discontinuation and reinitiation in hemodialysis patients: results from 7 European countries
por: Fuller, Douglas S., et al.
Publicado: (2019)

Comparison of the Oral Calcimimetics Evocalcet and Cinacalcet in East Asian Patients on Hemodialysis with Secondary Hyperparathyroidism
por: Ni, Zhaohui, et al.
Publicado: (2023)

The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism
por: Susantitaphong, Paweena, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ftf5ptsvnp0nrpdl0ffogb6qek